Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2000
10/25/2000EP1045839A2 Novel amines as pharmaceutical agents
10/25/2000EP1045836A1 Pyridones as src family sh2 domain inhibitors
10/25/2000EP1045834A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/25/2000EP1045833A1 2,3-substituted indole compounds as cox-2 inhibitors
10/25/2000EP0848713B1 Pyridiniminyl-1,2-benzisoxazoles and- benzisothiazoles as antipsychotic agents
10/25/2000CN1271358A Oxazolidinone derivatives and pharmaceutical compositions
10/25/2000CN1271357A bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors
10/25/2000CN1271355A Heterocyclic compounds and antitumor agent containing the same as active ingredient
10/25/2000CN1271345A Method for producing substituted 2-nitroguanideine derivatives
10/25/2000CN1270959A 4-phenyl pyridine derivatives
10/25/2000CN1057762C Substituted azadioxacycloalkens use as fungicides
10/24/2000US6136990 Anticancer agent; effective for treating breast cancer, lung cancer
10/24/2000US6136843 Indole derivatives useful as endothelin receptor antagonists
10/24/2000US6136837 α-substituted benzyl heterocyclic derivatives, intermediates for producing the same and agrochemical composition containing the same as active ingredient
10/24/2000US6136834 Tetrazole compounds and pharmaceutical agents containing such derivative
10/24/2000US6136832 Racemic mixtures and enantiomorphs
10/24/2000US6136831 Pyrazole derivatives and COX inhibitors containing them
10/24/2000US6136830 Sulphonyloxadiazolones and their use as microbicides
10/24/2000US6136828 Endothelin receptor antagonists
10/24/2000US6136826 Aminopiperidine compounds substituted with alkanoyl
10/24/2000US6136825 Sulfonamide compounds having 5-HT receptor activity
10/24/2000US6136812 Methods of administering AMPA receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
10/24/2000US6136344 Oral pharmaceutical dosage form
10/19/2000WO2000061581A1 Amine derivatives
10/19/2000WO2000061580A1 Substituted bicyclic heteroaryl compounds as integrin antagonists
10/19/2000WO2000061579A1 New endothelin converting enzyme inhibitors, their production and their use
10/19/2000WO2000061576A1 Triarylimidazoles
10/19/2000WO2000061564A1 Antiviral pyrimidinedione derivatives and process for the preparation thereof
10/19/2000WO2000061563A1 Antiviral pyrimidinedione derivatives and process for the preparation thereof
10/19/2000WO2000007996A8 Pyrazoles as estrogen receptor modulators
10/19/2000DE19916719A1 Neue ECE-Inhibitoren, ihre Herstellung und Verwendung New ECE inhibitors, their preparation and use
10/19/2000CA2369971A1 Aryl or heteroaryl fused imidazole derivatives, their pharmaceutical compositions and agents, and uses thereof
10/19/2000CA2369728A1 Substituted bicyclic heteroaryl compounds as integrin antagonists
10/18/2000EP1044969A2 Processes and intermediates for preparing anti-cancer compounds
10/18/2000EP1044197A2 New piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/18/2000EP1044191A2 Benzylidene pyrazolones, production and use thereof
10/18/2000EP1044188A1 Acylated 4-aminopyridine derivatives as pesticides and fungicides
10/18/2000EP1043977A1 Oral pharmaceutical pulsed release dosage form
10/18/2000EP1043976A1 Oral pharmaceutical extended release dosage form
10/18/2000CN1270584A Morpholinones as light stabilizers
10/18/2000CN1270518A Therapeutic or prophylactic agent for glomerulopathy
10/18/2000CN1270166A Derivatives of tricyclo-substituted isohydroxyloxime acid
10/18/2000CN1057523C Diphenyl oxazoline derivatives
10/17/2000US6133461 Process for producing amide derivatives and intermediates therefor
10/17/2000US6133457 Process for preparing pharmaceutical compounds
10/17/2000US6133442 For the treatment of disorders which are associated with endothelin activities, especially circulatory disorders such as hypertension, ischaemia, vasospasms and angina pectoris
10/17/2000US6133294 2-methoxyimino-2-(pyridinyloxymethyl) phenyl acetamides with 5 membered heterocyclic rings on the pyridine ring
10/17/2000US6133286 Antagonists; antiinflammatory agents for rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, psoriasis and other skin disorders, e.g., eczema, erythema, pruritus and acne; stroke, reperfusion injury, grafting
10/17/2000US6133276 A ligand inhibitor of a crf/crf-binding protein complex to effect increased levels of crf; 2,4-dioxo- or 2-thiocarbonyl-4-oxo-5-(hydrocarbyl(thio)carbonylaminomethyl)-6-hydroxy-hexa-hexahydropyrimidines; alzheimer's, obesity; low side effects
10/17/2000US6133275 3-phenylpyrrolidine alpha-1 adrenergic compounds
10/17/2000US6133268 1,4-disubstituted piperazines
10/17/2000CA2202031C Condensed indan derivatives and salts thereof
10/12/2000WO2000059902A2 Aryl sulfonyls as factor xa inhibitors
10/12/2000WO2000059884A1 Pharmaceutically active compounds and methods of use thereof
10/12/2000WO2000059868A1 Substituted aniline compounds
10/12/2000WO2000059510A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors
10/12/2000WO2000059506A1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD
10/12/2000WO2000059503A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059502A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059498A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000009106A3 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
10/12/2000WO1993012754A3 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
10/12/2000CA2373717A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2368703A1 Substituted aniline compounds
10/12/2000CA2368630A1 Aryl sulfonyls as factor xa inhibitors
10/12/2000CA2366944A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2366858A1 Sorbitol dehydrogenase inhibitors
10/12/2000CA2361734A1 Pharmaceutically active compounds and methods of use thereof
10/11/2000EP1043326A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043325A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043315A1 Steroid receptor modulator compounds and methods
10/11/2000EP1042320A1 New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists
10/11/2000EP1042315A1 Cyclic imide-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
10/11/2000EP1042296A1 Substituted isoquinoline derivatives and their use as anticonvulsants
10/11/2000EP1042295A1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
10/11/2000EP1042291A1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
10/11/2000EP1042290A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
10/11/2000EP1041982A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/11/2000EP1041980A1 Acyl guanidine sodium/proton exchange inhibitors and method
10/11/2000EP0859767B1 Fluoropropenyl oxadiazoles and the use thereof as pest control agents
10/11/2000EP0773930B1 Aromatic amino ethers as pain relieving agents
10/11/2000CN1269799A Piperidinylmethyloxazolidinone derivative
10/11/2000CN1269798A Stereoisomeric indole compounds, process for preparation of same and use thereof
10/11/2000CN1269363A Method for proparing heterocyclic compound
10/11/2000CN1057296C Morpholine and thiomorpholine tachykinin receptor antagonists and use
10/10/2000US6130336 Reacting an oxazolidine with 7-trihaloacetylbaccatin in a solvent; deblocking with ammonia
10/10/2000US6130243 1,4-benzodioxin derivatives
10/10/2000US6130239 Inhibit cyclin-dependent kinases
10/10/2000US6130234 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
10/10/2000US6130231 Integrin receptor antagonists
10/05/2000WO2000058405A2 Squaraine dyes
10/05/2000WO2000058315A1 Organometallic complex molecule and organic electroluminescent device using the same
10/05/2000WO2000058313A1 4-substituted quinoline derivatives as gaba receptor ligands
10/05/2000WO2000058306A1 Substituted benzoylpyrazoles as herbicides
10/05/2000WO2000058305A1 Novel compounds
10/05/2000WO2000058303A1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
10/05/2000WO2000058301A1 N-[2-(4-aminophyl)ethyl]-2,3-dihydro-1,4-benzodioxine-2-methanamine, production and therapeutic use thereof
10/05/2000WO2000058292A1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
10/05/2000WO2000058288A1 Pyridine-2,3-dicarboxylic acid diamides
10/05/2000WO2000042026B1 Non-peptide glp-1 agonists
1 ... 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 ... 647